Security key
254604101
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON)
CUSIP: 254604101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 37,778,373
- Total 13F shares
- 27,309,249
- Share change
- -582,543
- Total reported value
- $1,342,089,295
- Put/Call ratio
- 99%
- Price per share
- $49.14
- Number of holders
- 130
- Value change
- -$26,632,908
- Number of buys
- 81
- Number of sells
- 37
Report period
Q3 2024
Institutions
130
Top holders
10
IRON full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Disc Medicine, Inc. SEC filings
Disc Medicine, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 254604101
Recent filing periods:
Top shareholders of IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Braden M. Leonard |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,247,500
|
$354,993,375 | — | 26 Oct 2022 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
7.2%
|
2,704,718
|
$121,901,640 | — | 30 Jun 2024 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
6.6%
|
2,509,456
|
$113,101,182 | — | 30 Jun 2024 | |
| Atlas Venture Fund X, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,600,512
|
$108,274,637 | — | 23 Jan 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
4.8%
|
1,795,735
|
$80,933,776 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4.7%
|
1,785,571
|
$80,475,685 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.6%
|
1,756,495
|
$79,165,230 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
4.6%
|
1,754,834
|
$79,090,368 | — | 30 Jun 2024 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,090,772
|
$73,790,726 | — | 28 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.8%
|
1,437,542
|
$64,790,018 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3%
|
1,122,194
|
$50,578,000 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
1,111,424
|
$50,091,879 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.7%
|
1,023,265
|
$46,118,554 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
2.4%
|
925,000
|
$41,689,750 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2%
|
761,429
|
$34,317,605 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
618,501
|
$27,875,840 | — | 30 Jun 2024 | |
| James B. Tananbaum |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
428,745
mixed-class rows
|
$27,837,975 | — | 04 Oct 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
592,795
|
$26,717,271 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
553,437
|
$24,943,406 | — | 30 Jun 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
1.3%
|
503,089
|
$22,674,221 | — | 30 Jun 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.3%
|
486,957
|
$21,947,152 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.2%
|
445,873
|
$20,062,056 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
1.1%
|
413,097
|
$18,618,282 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
403,736
|
$18,200,080 | — | 30 Jun 2024 | |
| Atlas Venture Opportunity Fund II, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
218,326
|
$14,769,754 | — | 29 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.85%
|
321,521
|
$14,490,951 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.83%
|
312,049
|
$14,064,049 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.81%
|
305,658
|
$13,776,006 | — | 30 Jun 2024 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
0.79%
|
299,069
|
$13,479,040 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.71%
|
267,863
|
$12,072,585 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.65%
|
244,928
|
$11,038,905 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.57%
|
216,701
|
$9,766,714 | — | 30 Jun 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.57%
|
215,260
|
$9,701,768 | — | 30 Jun 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.51%
|
192,000
|
$8,653,440 | — | 30 Jun 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.44%
|
166,500
|
$7,504,155 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.4%
|
150,000
|
$6,760,500 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
141,153
|
$6,361,766 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.37%
|
138,907
|
$6,260,538 | — | 30 Jun 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.36%
|
136,096
|
$6,133,847 | — | 30 Jun 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.29%
|
109,319
|
$4,927,007 | — | 30 Jun 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.26%
|
98,675
|
$4,585,427 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
101,187
|
$4,560,498 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
98,934
|
$4,458,963 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
98,375
|
$4,433,762 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.24%
|
92,139
|
$4,152,705 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
77,678
|
$3,500,947 | — | 30 Jun 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.16%
|
61,000
|
$2,749,270 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.16%
|
60,589
|
$2,730,747 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.15%
|
58,044
|
$2,616,043 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.15%
|
55,921
|
$2,520,359 | — | 30 Jun 2024 |
Institutional Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q3 2024
As of 30 Sep 2024,
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,309,249 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
119
Q3 2024 holders
130
Holder diff
11
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.